BCL2L1 and pulmonary fibrosis: Both ABT-737 and ABT-263 treatment significantly reduced expression of Bcl-xl and Bcl-w in irradiation-induced lung fibrosis mouse models, which in turn decreased the numbers of senescent cells and ameliorated lung fibrosis (Pan et al., 2017).